Professor, Medicine - Endocrinology, Gerontology, and Metabolism, Stanford University Medical Center
Endocrinology
Dr. Andrew R. Hoffman, MD
|
|
Give Review
Doctor Andrew R. Hoffman, MD works in the field of Endocrinology. He went to medical school at Stanford University School of Medicine. Stanford University School of Medicine is a one of the best medicals schools. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. He received 4 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification" and "Elected Member". Doctor Andrew R. Hoffman, MD is also published. He has 70 publications published. The lastest publication: "Risk Factors for Hip Fracture in Older Men: The Osteoporotic Fractures in Men Study (MrOS).'
Publications
- Sex hormones, sex hormone binding globulin, and vertebral fractures in older men.
- Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon Cancer cells.
- A Novel Inherited Mutation in PRKAR1A Abrogates PreRNA Splicing in a Carney Complex Family.
- Growth Hormone Safety Workshop Position Paper: a critical appraisal of recombinant human growth hormone therapy in children and adults.
- Subclinical Thyroid Dysfunction and Frailty among Older Men.
- Evaluation of the Usefulness of Consensus Definitions of Sarcopenia in Older Men: Results from the Observational Osteoporotic Fractures in Men Cohort Study.
- Erratum to: Six Degree-of-Freedom Measurements of Human Mild Traumatic Brain Injury.
- An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies.
- Six Degree-of-Freedom Measurements of Human Mild Traumatic Brain Injury.
- Aberrant allele-switch imprinting of a novel IGF1R intragenic antisense non-coding RNA in breast Cancers.
- Epigenetic reprogramming reverses the malignant epigenoType of the MMP/TIMP axis genes in tumor cells.
- Growth hormone should be used only for approved indications.
- Association Between Thyroid Function and Objective and Subjective Sleep Quality in Older Men: The Osteoporotic Fractures in Men (MrOs) Study.
- Implications of COMT long-range interactions on the phenotypic variability of 22q11.2 deletion syndrome.
- Chromatin looping is needed for iPSC induction.
- Cyclic hypobaric hypoxia improves markers of glucose Metabolism in middle-aged men.
- Intrachromosomal Looping Is Required for Activation of Endogenous Pluripotency Genes during Reprogramming.
- Validation of FRC, a Fracture Risk Assessment Tool, in a Cohort of Older Men: The Osteoporotic Fractures in Men (MrOS) Study.
- Long-Term Surveillance of Growth Hormone Therapy.
- Higher Testosterone Levels Are Associated with Less Loss of Lean Body Mass in Older Men.
- IGFBP-2 Enhances VEGF Gene Promoter Activity and Consequent Promotion of Angiogenesis by Neuroblastoma Cells.
- Optimized clinical performance of growth hormone with an expanded genetic code.
- Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II.
- The Endocrine System and Sarcopenia: Potential Therapeutic Benefits.
- Potentiation of tumor radiotherapy by a radiation-inducible oncolytic and oncoapoptotic adenovirus in cervical Cancer xenografts.
- Patient guide to hyperprolactinemia diagnosis and treatment.
- Putative tumor suppressor miR-145 inhibits colon Cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.
- Associated Chromosome Trap for Identifying Long-range DNA Interactions.
- Targeted tumor gene therapy based on loss of IGF2 imprinting.
- Targeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3'-UTR microRNA.
- Association of a high mobility group gene (HMGA2) variant with bone mineral density.
- Nocturnal Arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep Disorders in older men (MrOS sleep) study.
- Glucocorticoid receptor activation of the Ciz1-Lcn2 locus by long range interactions.
- Enhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors.
- CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop.
- A complex deoxyribonucleic acid looping configuration associated with the silencing of the maternal Igf2 allele.
- Systematic review: the effects of growth hormone on athletic performance.
- Do capacitively coupled electric fields accelerate tibial stress fracture healing? A randomized controlled trial.
- Long-term safety of recombinant human growth hormone in turner syndrome.
- Growth hormone replacement therapy in adults with growth hormone Deficiency improves maximal oxygen consumption independently of dosing regimen or physical activity.
- Generation of novel adipocyte monolayer cultures from embryonic stem cells.
- Epigenetics of long-range chromatin interactions.
- Systematic review: the safety and efficacy of growth hormone in the healthy elderly.
- Directing DNA methylation to inhibit gene expression.
- Endocrine responses to acute and chronic high-altitude exposure (4,300 meters): modulating effects of caloric restriction.
- CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1.
- Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter construct.
- Three weeks of caloric restriction alters protein Metabolism in normal-weight, young men.
- Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewi...
- Antioxidant supplementation does not attenuate oxidative stress at high altitude.
- Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly.
- Treatment of diabetic ketoacidosis: should mode of insulin administration dictate use of intensive care facilities?
- Epigenetic regulation of the taxol resistance-associated gene TRAG-3 in human tumors.
- Growth hormone (GH) replacement therapy in adult-onset gh Deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled tr...
- The histone code regulating expression of the imprinted mouse Igf2r gene.
- Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.
- CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.
- Five weeks of insulin-like growth factor-I treatment does not alter glucose kinetics or insulin sensitivity during a hyperglycemic clamp in older women.
- Bone mineral density in pediatric transplant recipients.
- A novel orthotopic tumor model to study growth factors and oncogenes in hepatocarcinogenesis.
- Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
- Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
- A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma.
- An imprinted PEG1/MEST antisense expressed predominantly in human testis and in mature spermatozoa.
- Targeted gene suppression by inducing de novo DNA methylation in the gene promoter.
- Rapid and Efficient Conversion of Integration-Free Human Induced Pluripotent Stem Cells to GMP-Grade Culture Conditions.
- Genomic interaction profiles in breast Cancer reveal altered chromatin architecture.
- Successful long-term treatment of Cushing disease with mifepristone (RU486).
- Risk Factors for Hip Fracture in Older Men: The Osteoporotic Fractures in Men Study (MrOS).
Schools
Stanford University
Mass Genl Hospital
Massachusetts General Hospital
Conditions Treated
- Acromegaly and Gigantism
- Adrenal Insufficiency
- Adrenogenital Disorders
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Elected Member
Education
-
Massachusetts General Hospital -
Stanford University School of Medicine
Hospital
-
VA Palo Alto Health Care System -
Stanford Health Care
Drug Facts
| NPI NUMBER | 1619924685 | |
| NPPES Provider LastName | HOFFMAN | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 943041207 | |
| NPPES Provider State | CA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 295.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619924685 |
| Last Name Of The Provider | HOFFMAN |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
Dr. Fahim Abbasi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chrysoula Dosiou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronadip Banerjee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil Gesundheit, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marilyn Tan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fredric B. Kraemer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracey McLaughlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danit Ariel, MD
This Doctor is OpenDoctor Recommended.
|